Epidemiology of travel-associated dengue from 2007 to 2022: A GeoSentinel analysis
Journal of Travel Medicine · 2024
DOI: 10.1093/jtm/taae089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Travel Medicine, 2024. Verfasst von Alexandre Duvignaud und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Tropical Medicine, Division of Tropical Medicine and Clinical International Health, Hôpital Pellegrin, CHU Bord…. Hauptthemen laut MEDLINE: Dengue, Travel, Dengue Virus. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: GeoSentinel Foundation, Public Health Agency of Canada, NCEZID CDC HHS.
Abstract (Originalsprache)
Background
Dengue is a leading cause of febrile illness among international travellers. We aimed to describe the epidemiology and clinical characteristics of imported dengue in returning travellers evaluated at GeoSentinel sites from 2007 to 2022.
Methods
We retrieved GeoSentinel records of dengue among travellers residing in non-endemic countries. We considered dengue confirmed when diagnosed by a positive dengue virus (DENV)–specific reverse-transcriptase polymerase chain reaction, positive NS-1 antigen and/or anti-DENV IgG seroconversion, and probable when diagnosed by single anti-DENV IgM or high-titre anti-DENV IgG detection. Severe dengue was defined as evidence of clinically significant plasma leakage or bleeding, organ failure, or shock, according to the 2009 World Health Organization guidance. Complicated dengue was defined as either severe dengue or dengue with presence of any warning sign. Analyses were descriptive.
Results
This analysis included 5958 travellers with confirmed (n = 4859; 81.6%) or probable (n = 1099; 18.4%) dengue. The median age was 33 years (range: <1–91); 3007 (50.5%) travellers were female. The median travel duration was 21 days (interquartile range [IQR]: 15–32). The median time between illness onset and GeoSentinel site visit was 7 days (IQR: 4–15). The most frequent reasons for travel were tourism (67.3%), visiting friends or relatives (12.2%) and business (11.0%). The most frequent regions of acquisition were South East Asia (50.4%), South Central Asia (14.9%), the Caribbean (10.9%) and South America (9.2%). Ninety-five (1.6%) travellers had complicated dengue, of whom 27 (0.5%) had severe dengue and one died. Of 2710 travellers with data available, 724 (26.7%) were hospitalized. The largest number of cases (n = 835) was reported in 2019.
Conclusions
A broad range of international travellers should be aware of the risk of acquiring dengue and receive appropriate pre-travel counselling regarding preventive measures. Prospective cohort studies are needed to further elucidate dengue risk by destination and over time, as well as severe outcomes and prolonged morbidity (long dengue) due to travel-related dengue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases and Tropical Medicine, Division of Tropical Medicine and Clinical International Health, Hôpital Pellegrin, CHU Bordeaux, Bordeaux, France.
- Global Health in the Global South - University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219 - Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health…
- Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, Cambridge, MA, USA.
- Faculty of Medicine, Harvard Medical School, Boston, MA, USA.
- Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore-Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
ORCID-Profile: Alexandre Duvignaud, Rhett J Stoney, Daniel L Bourque, Bhawana Amatya, Francesca F Norman, Marta Díaz-Menéndez, Daniel Camprubí-Ferrer, Loic Epelboin, Gilles Eperon, Michael Libman
Förderung
- GeoSentinel Foundation
- Public Health Agency of Canada
- NCEZID CDC HHS
- US Centers for Disease Control and Prevention
- International Society of Travel Medicine
- ISTM
Zitieren
APA
Duvignaud, A., Stoney, R. J., Angelo, K. M., Chen, L. H., Cattaneo, P., Motta, L., Gobbi, F. G., Bottieau, E., Bourque, D. L., Popescu, C. P., Glans, H., Asgeirsson, H., Oliveira-Souto, I., Vaughan, S. D., Amatya, B., Norman, F. F., Waggoner, J., Díaz-Menéndez, M., Beadsworth, M., …, & GeoSentinel Network (2024). Epidemiology of travel-associated dengue from 2007 to 2022: A GeoSentinel analysis. Journal of Travel Medicine. https://doi.org/10.1093/jtm/taae089
Vancouver
Duvignaud A, Stoney RJ, Angelo KM, Chen LH, Cattaneo P, Motta L, et al. Epidemiology of travel-associated dengue from 2007 to 2022: A GeoSentinel analysis. Journal of Travel Medicine. 2024. doi:10.1093/jtm/taae089
BibTeX
@article{Duvignaud2024,
author = {Duvignaud, Alexandre and Stoney, Rhett J and Angelo, Kristina M and Chen, Lin H and Cattaneo, Paolo and Motta, Leonardo and Gobbi, Federico G and Bottieau, Emmanuel and Bourque, Daniel L and Popescu, Corneliu P and Glans, Hedvig and Asgeirsson, Hilmir and Oliveira-Souto, Ines and Vaughan, Stephen D and Amatya, Bhawana and Norman, Francesca F and Waggoner, Jesse and Díaz-Menéndez, Marta and Beadsworth, Michael and Odolini, Silvia and Camprubí-Ferrer, Daniel and Epelboin, Loic and Connor, Bradley A and Eperon, Gilles and Schwartz, Eli and Libman, Michael and Malvy, Denis and Hamer, Davidson H and Huits, Ralph and GeoSentinel Network, GeoSentinel Network},
title = {Epidemiology of travel-associated dengue from 2007 to 2022: A GeoSentinel analysis},
journal = {Journal of Travel Medicine},
year = {2024},
doi = {10.1093/jtm/taae089}
}
EUVIMED